Krónikus mieloid leukémia (CML): vizsgálatok itt: Japán
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Fukuoka, Saitama, Yokohama
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Kobe
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Nagoya, Tokyo
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Ehime, Kyoto, Okayama, Osaka, Sapporo, Tochigi, Tokyo, Yamagata, Yamanashi
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - 1. fázisTaking peopleELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
- Where
- Akita, Sapporo, Shinjuku-ku, Suita-shi
- Életkor
- 18 év and over
- People
- 21
- Run by
- Enliven Therapeutics
See details and how to joinNCT06787144 - No phaseTaking peopleInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Tokyo
- Életkor
- Up to 18 év
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735